Target intelligence / Profile preview

Ribosomal protein L28 pseudogene 1 (RPL28P1)

Target: RPL28P1
Molecular classification: Other (Pseudogene)

Overview

Ribosomal protein L28 pseudogene 1 (RPL28P1) is a processed pseudogene related to the ribosomal protein L28 gene. Pseudogenes are DNA sequences similar to known genes but are typically nonfunctional due to disabling mutations or truncations, and do not encode functional proteins. RPL28P1 does not produce a functional protein and thus is not considered a therapeutic drug target, nor is it implicated in disease biology or known to interact with any drugs. Its nomenclature and properties are distinct from the functional ribosomal protein L28 gene (RPL28), and no biological, pathological, or pharmacological functions are assigned to RPL28P1.

Other names: bcm2489

Beyond the preview

Go deeper on Ribosomal protein L28 pseudogene 1 (RPL28P1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Explore the programs pursuing this target and their development progress.

Drug candidates
Developers
Development stage

Clinical trials

Follow the clinical studies evaluating therapies directed at this target.

Trial design
Status
Readouts

Competitive landscape

Compare approaches across drug candidates, modalities, and indications.

Programs
Modalities
Indications

Literature & evidence

Investigate the research and source evidence behind target biology and development.

Publications
Sources
Analysis

Patents

Explore patent activity around therapies and technologies addressing this target.

Patents
Assignees
Technologies

Research & analysis

Connect target biology, drug development, and emerging evidence in your research.

Biology
Development news
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L28 pseudogene 1 (RPL28P1).

Explore the full profile